The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastrointestinal Cancer Treatment Market Research Report 2025
Synopsis
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
The global Gastrointestinal Cancer Treatment market was valued at US$ 4012 million in 2023 and is anticipated to reach US$ 9225.2 million by 2030, witnessing a CAGR of 12.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Treatment.
Report Scope
The Gastrointestinal Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.
Segment by Type
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
The global Gastrointestinal Cancer Treatment market was valued at US$ 4012 million in 2023 and is anticipated to reach US$ 9225.2 million by 2030, witnessing a CAGR of 12.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Treatment.
Report Scope
The Gastrointestinal Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.
Segment by Type
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Targeted Drugs Therapy
1.2.4 Chemo Therapy
1.2.5 Adjuvant Chemotherapy
1.2.6 Radiation Therapy
1.3 Market by Application
1.3.1 Global Gastrointestinal Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2019-2030)
2.2 Gastrointestinal Cancer Treatment Growth Trends by Region
2.2.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Cancer Treatment Market Dynamics
2.3.1 Gastrointestinal Cancer Treatment Industry Trends
2.3.2 Gastrointestinal Cancer Treatment Market Drivers
2.3.3 Gastrointestinal Cancer Treatment Market Challenges
2.3.4 Gastrointestinal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue
3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue
3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2023
3.5 Gastrointestinal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Gastrointestinal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Cancer Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Cancer Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Cancer Treatment Market Size (2019-2030)
6.2 North America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Cancer Treatment Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Cancer Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Cancer Treatment Market Size (2019-2030)
7.2 Europe Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Cancer Treatment Market Size (2019-2030)
9.2 Latin America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction
11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 F. Hoffmann
11.2.1 F. Hoffmann Company Detail
11.2.2 F. Hoffmann Business Overview
11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction
11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.2.5 F. Hoffmann Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Gastrointestinal Cancer Treatment Introduction
11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction
11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.5.5 Novartis AG Recent Development
11.6 Otsuka Holdings
11.6.1 Otsuka Holdings Company Detail
11.6.2 Otsuka Holdings Business Overview
11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction
11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.6.5 Otsuka Holdings Recent Development
11.7 Stryker Corporation
11.7.1 Stryker Corporation Company Detail
11.7.2 Stryker Corporation Business Overview
11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction
11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.7.5 Stryker Corporation Recent Development
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Detail
11.8.2 Boston Scientific Corporation Business Overview
11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction
11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.8.5 Boston Scientific Corporation Recent Development
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Detail
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction
11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.9.5 Johnson and Johnson Recent Development
11.10 CONMED Corporation
11.10.1 CONMED Corporation Company Detail
11.10.2 CONMED Corporation Business Overview
11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction
11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.10.5 CONMED Corporation Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction
11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 Celltrion Inc
11.13.1 Celltrion Inc Company Detail
11.13.2 Celltrion Inc Business Overview
11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction
11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.13.5 Celltrion Inc Recent Development
11.14 Amgen Limited
11.14.1 Amgen Limited Company Detail
11.14.2 Amgen Limited Business Overview
11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction
11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.14.5 Amgen Limited Recent Development
11.15 Celgene Corporation
11.15.1 Celgene Corporation Company Detail
11.15.2 Celgene Corporation Business Overview
11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction
11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.15.5 Celgene Corporation Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction
11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.16.5 Sanofi Recent Development
11.17 Mylan N.V.
11.17.1 Mylan N.V. Company Detail
11.17.2 Mylan N.V. Business Overview
11.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Introduction
11.17.4 Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.17.5 Mylan N.V. Recent Development
11.18 Samsung Bioepis
11.18.1 Samsung Bioepis Company Detail
11.18.2 Samsung Bioepis Business Overview
11.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Introduction
11.18.4 Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.18.5 Samsung Bioepis Recent Development
11.19 Teva Pharmaceutical Industries Ltd.
11.19.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.19.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Introduction
11.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2019-2024)
11.19.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Targeted Drugs Therapy
Table 4. Key Players of Chemo Therapy
Table 5. Key Players of Adjuvant Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Gastrointestinal Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gastrointestinal Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Gastrointestinal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Gastrointestinal Cancer Treatment Market Share by Region (2019-2024)
Table 11. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Gastrointestinal Cancer Treatment Market Share by Region (2025-2030)
Table 13. Gastrointestinal Cancer Treatment Market Trends
Table 14. Gastrointestinal Cancer Treatment Market Drivers
Table 15. Gastrointestinal Cancer Treatment Market Challenges
Table 16. Gastrointestinal Cancer Treatment Market Restraints
Table 17. Global Gastrointestinal Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Gastrointestinal Cancer Treatment Market Share by Players (2019-2024)
Table 19. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2023)
Table 20. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastrointestinal Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Gastrointestinal Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 28. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 30. Global Gastrointestinal Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 32. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 34. North America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Gastrointestinal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Gastrointestinal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Gastrointestinal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Gastrointestinal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Gastrointestinal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 49. Eli Lilly Company Detail
Table 50. Eli Lilly Business Overview
Table 51. Eli Lilly Gastrointestinal Cancer Treatment Product
Table 52. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 53. Eli Lilly Recent Development
Table 54. F. Hoffmann Company Detail
Table 55. F. Hoffmann Business Overview
Table 56. F. Hoffmann Gastrointestinal Cancer Treatment Product
Table 57. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 58. F. Hoffmann Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Gastrointestinal Cancer Treatment Product
Table 62. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Gastrointestinal Cancer Treatment Product
Table 67. Merck Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Novartis AG Company Detail
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Gastrointestinal Cancer Treatment Product
Table 72. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. Otsuka Holdings Company Detail
Table 75. Otsuka Holdings Business Overview
Table 76. Otsuka Holdings Gastrointestinal Cancer Treatment Product
Table 77. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 78. Otsuka Holdings Recent Development
Table 79. Stryker Corporation Company Detail
Table 80. Stryker Corporation Business Overview
Table 81. Stryker Corporation Gastrointestinal Cancer Treatment Product
Table 82. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 83. Stryker Corporation Recent Development
Table 84. Boston Scientific Corporation Company Detail
Table 85. Boston Scientific Corporation Business Overview
Table 86. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product
Table 87. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 88. Boston Scientific Corporation Recent Development
Table 89. Johnson and Johnson Company Detail
Table 90. Johnson and Johnson Business Overview
Table 91. Johnson and Johnson Gastrointestinal Cancer Treatment Product
Table 92. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 93. Johnson and Johnson Recent Development
Table 94. CONMED Corporation Company Detail
Table 95. CONMED Corporation Business Overview
Table 96. CONMED Corporation Gastrointestinal Cancer Treatment Product
Table 97. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 98. CONMED Corporation Recent Development
Table 99. Bristol-Myers Squibb Company Detail
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product
Table 102. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Pfizer Company Detail
Table 105. Pfizer Business Overview
Table 106. Pfizer Gastrointestinal Cancer Treatment Product
Table 107. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Celltrion Inc Company Detail
Table 110. Celltrion Inc Business Overview
Table 111. Celltrion Inc Gastrointestinal Cancer Treatment Product
Table 112. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 113. Celltrion Inc Recent Development
Table 114. Amgen Limited Company Detail
Table 115. Amgen Limited Business Overview
Table 116. Amgen Limited Gastrointestinal Cancer Treatment Product
Table 117. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 118. Amgen Limited Recent Development
Table 119. Celgene Corporation Company Detail
Table 120. Celgene Corporation Business Overview
Table 121. Celgene Corporation Gastrointestinal Cancer Treatment Product
Table 122. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 123. Celgene Corporation Recent Development
Table 124. Sanofi Company Detail
Table 125. Sanofi Business Overview
Table 126. Sanofi Gastrointestinal Cancer Treatment Product
Table 127. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 128. Sanofi Recent Development
Table 129. Mylan N.V. Company Detail
Table 130. Mylan N.V. Business Overview
Table 131. Mylan N.V. Gastrointestinal Cancer Treatment Product
Table 132. Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 133. Mylan N.V. Recent Development
Table 134. Samsung Bioepis Company Detail
Table 135. Samsung Bioepis Business Overview
Table 136. Samsung Bioepis Gastrointestinal Cancer Treatment Product
Table 137. Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 138. Samsung Bioepis Recent Development
Table 139. Teva Pharmaceutical Industries Ltd. Company Detail
Table 140. Teva Pharmaceutical Industries Ltd. Business Overview
Table 141. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product
Table 142. Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 143. Teva Pharmaceutical Industries Ltd. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gastrointestinal Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Surgery Features
Figure 4. Targeted Drugs Therapy Features
Figure 5. Chemo Therapy Features
Figure 6. Adjuvant Chemotherapy Features
Figure 7. Radiation Therapy Features
Figure 8. Global Gastrointestinal Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Gastrointestinal Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Gastrointestinal Cancer Treatment Report Years Considered
Figure 15. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Gastrointestinal Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 18. Global Gastrointestinal Cancer Treatment Market Share by Players in 2023
Figure 19. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2023
Figure 21. North America Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Gastrointestinal Cancer Treatment Market Share by Country (2019-2030)
Figure 23. United States Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Gastrointestinal Cancer Treatment Market Share by Country (2019-2030)
Figure 27. Germany Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2019-2030)
Figure 35. China Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Gastrointestinal Cancer Treatment Market Share by Country (2019-2030)
Figure 43. Mexico Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Country (2019-2030)
Figure 47. Turkey Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Gastrointestinal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 50. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 52. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 53. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 54. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 55. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 56. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 57. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 58. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 60. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 61. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 62. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 63. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 64. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 65. Mylan N.V. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 66. Samsung Bioepis Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
